山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (2): 105-109.doi: 10.6040/j.issn.1673-3770.0.2020.341

• 临床研究 • 上一篇    下一篇

优化脉冲光联合睑板腺按摩治疗睑板腺功能障碍的临床效果观察

李威1,张斌2   

  1. 1. 沈阳爱尔眼科医院, 辽宁 沈阳 110041;
    2. 沈阳何氏眼科医院, 辽宁 沈阳 110031
  • 发布日期:2021-04-20
  • 通讯作者: 张斌. E-mail:sddndzsy@163.com

Effects of optimal pulse technology combined with meibomian gland massage to treat meibomian gland dysfunction

LI Wei1, ZHANG Bin2   

  1. 1. Shenyang Ai'er Eye Hospital, Shenyang 110041, Liaoning, China;
    2. Shenyang HE Eye Specialist Hospital, Shenyang 110031, Liaoning, China
  • Published:2021-04-20

PDF (PC)

344

摘要： 目的 研究优化脉冲光联合睑板腺按摩治疗睑板腺功能障碍的临床效果。 方法 采用前瞻性病例对照研究,观察诊断为睑板腺功能障碍的患者86例172眼。将患者随机分为试验组和对照组,每组43例86眼。两组患者给予优化脉冲光治疗,每4周1次,共4次,试验组在每次治疗后进行睑板腺按摩。记录患者治疗前及首次治疗后4、8、12及16周时患者眼表疾病指数(OSDI)评分、非侵入性泪膜破裂时间(NITBUT)、非侵入性泪河高度(NITMH)、睑板腺评分(MGS)及睑板腺分泌物评分(MGYSS)等数据,进行统计学分析。 结果 两组治疗后各时间点除NITMH、MGS外各项指标均较治疗前有明显改善(P<0.001)。试验组OSDI评分结果在治疗4周时与对照组无差异(P=0.857),其他时间点均优于对照组(P8周=0.002,P12周=0.024,P16周<0.001)。试验组NITBUT各时间点评分结果均优于对照组(P<0.001)。试验组MGYSS各时间点评分均优于对照组(P4周<0.001,P8周=0.005,P12周=0.045,P16周=0.013)。 结论 优化脉冲光技术联合睑板腺按摩能缓解症状、稳定泪膜、减轻炎症,治疗MGD效果明显。

关键词: 脉冲光, 睑板腺按摩, 睑板腺功能障碍, 治疗, 临床效果

Abstract: Objective To evaluate the clinical effect of optimal pulse technology combined with meibomian gland massage to treat meibomian gland dysfunction. Methods We performed a prospective analysis of 172 eyes of 86 patients with meibomian gland dysfunction from May to December 2019. The study population was randomly divided into observation and control groups, each including 86 eyes of 43 patients. All patients were treated with optimal pulse technology for a total of 4 times, once every 4 weeks. Patients in the observation group underwent meibomian gland massage after each treatment. The ocular surface disease index(OSDI)score, noninvasive tear break-up time(NITBUT), noninvasive tear meniscus height(NITMH), meibomian gland score(MGS), and meibomian gland yielding secretion score(MGYSS)were recorded before and after the first treatment. Results The indices recorded at each time point, except for NITMH and MGS, improved significantly(P<0.001). The OSDI score did not differ between the two groups at 4 weeks after the treatment(P=0.857)and was better in the observation group than in the control group at other time points(P8 weeks=0.002, P12 weeks=0.024, P16 weeks<0.001). NITBUT was better in the observation group than in the control group at each time point(P<0.001; P4 weeks<0.001, P8 weeks=0.005, P12 weeks=0.045, P16 weeks=0.013). Conclusions The optimal pulse technology combined with meibomian gland massage can relieve symptoms, stabilize tear film, and reduce inflammation. The treatment effect is obvious.

Key words: Optimal pulse technology, Meibomian gland massage, Meibomian gland dysfunction, Treatment, Clinical effect

中图分类号: 

  • R777
[1] 我国睑板腺功能障碍诊断与治疗专家共识[J]. 中华眼科杂志, 2017, 53(9). 657-661. doi:10.3760/cma.j.issn.0412-4081.2017.09.005.
[2] Geerling G, Tauber J, Baudouin C, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction[J]. Invest Ophthalmol Vis Sci, 2011, 52(4): 2050. doi:10.1167/iovs.10-6997g.
[3] Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study[J]. Photomed Laser Surg, 2015, 33(1): 41-46. doi:10.1089/pho.2014.3819.
[4] 宁玉贤, 赵少贞. 非侵入性眼表综合分析仪及Lipiview眼表面干涉仪评估儿童干眼的特点[J]. 眼科新进展, 2019, 39(1): 72-74. doi: 10.13389/j.cnki.rao.2019.0016. NING Yuxian, ZHAO Shaozhen. Evaluation of dry eye in children by Keratograph 5 M and lipiview ocular surface interometry[J]. Recent Advances in Ophthalmology, 2019, 39(1): 72-74. doi: 10.13389/j.cnki.rao.2019.0016.
[5] Schaumberg DA, Nichols JJ, Papas EB, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD[J]. Invest Ophthalmol Vis Sci, 2011, 52(4): 1994-2005. doi:10.1167/iovs.10-6997e.
[6] 高妍, 李春晖, 王效武. 红外线睑板腺仪对睑板腺功能障碍患者综合治疗前后观察[J]. 中国实用眼科杂志, 2016, 34(11): 1211-1214. doi:10.3760/cma.j.issn.1006-4443.2016.11.021. GAO Yan, LI Chunhui, WANG Xiaowu. Effect observation of comprehensive therapy in the treatment of MGD by infrared meibography[J]. Chinese Journal of Practical Ophthalmology, 2016, 34(11): 1211-1214. doi:10.3760/cma.j.issn.1006-4443.2016.11.021.
[7] Chao C, Tong L. Tear lactoferrin and features of ocular allergy in different severities of meibomian gland dysfunction[J]. Optom Vis Sci, 2018, 95(10): 930-936. doi:10.1097/opx.0000000000001285.
[8] Green-Church KB, Butovich I, Willcox M, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease[J]. Invest Ophthalmol Vis Sci, 2011, 52(4): 1979-1993. doi:10.1167/iovs.10-6997d.
[9] Kashkouli MB, Fazel AJ, Kiavash V, et al. Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial[J]. Br J Ophthalmol, 2015, 99(2): 199-204. doi:10.1136/bjophthalmol-2014-305410.
[10] Geerling G, Baudouin C, Aragona P, et al. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: Proceedings of the OCEAN group meeting[J]. Ocular Surf, 2017, 15(2): 179-192. doi:10.1016/j.jtos.2017.01.006.
[11] 董雪青, 高莹莹, 赵华轩, 等. 改良和传统睑板腺压榨手法治疗睑板腺功能障碍的比较[J]. 中国实用眼科杂志, 2015, 33(1): 72-77. doi:10.3760/cma.j.issn.1006-4443.2015.01.019. DONG Xueqing, GAO Yingying, ZHAO Huaxuan, et al. Improved method of meibomian gland compression in the treatment of meibomian gland dysfunction[J]. Chinese Journal of Practical Ophthalmology, 2015, 33(1): 72-77. doi:10.3760/cma.j.issn.1006-4443.2015.01.019.
[12] 陈国玲, 考欣, 张晗, 等. 睑板腺管按摩治疗睑板腺功能障碍的临床观察[J]. 中国医学科学院学报, 2015, 37(4): 415-419. doi:10.3881/j.issn.1000-503X.2015.04.008. CHEN Guoling, KAO Xin, ZHANG Han, et al. Effectiveness of meibomian gland tube massage in treating meibomian gland dysfunction[J]. Acta Academiae Medicinae Sinicae, 2015, 37(4): 415-419. doi:10.3881/j.issn.1000-503X.2015.04.008.
[13] Campolmi P, Bonan P, Cannarozzo G, et al. Intense pulsed light in the treatment of non-aesthetic facial and neck vascular lesions: report of 85 cases[J]. J Eur Acad Dermatol Venereol, 2011, 25(1): 68-73. doi:10.1111/j.1468-3083.2010.03700.x.
[14] Vora GK, Gupta PK. Intense pulsed light therapy for the treatment of evaporative dry eye disease[J]. Curr Opin Ophthalmol, 2015, 26(4): 314-318. doi:10.1097/icu.0000000000000166.
[15] Craig JP, Chen YH, Turnbull PRK. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction[J]. Invest Ophthalmol Vis Sci, 2015, 56(3): 1965. doi:10.1167/iovs.14-15764.
[16] Gayán E, Condón S, Álvarez I. Biological aspects in food preservation by ultraviolet light: a review[J]. Food Bioprocess Technol, 2014, 7(1): 1-20. doi:10.1007/s11947-013-1168-7.
[17] 荣蓓, 涂平, 汤韵, 等. 强脉冲光联合睑板腺按摩治疗睑板腺功能障碍的短期疗效观察[J]. 中华眼科杂志, 2017, 53(9): 675-681. doi:10.3760/cma.j.issn.0412-4081.2017.09.008. RONG Bei, TU Ping, TANG Yun, et al. Evaluation of short-term effect of intense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction[J]. Chinese Journal of Ophthalmology, 2017, 53(9): 675-681. doi:10.3760/cma.j.issn.0412-4081.2017.09.008.
[18] 王梦格, 谌丹, 李丽平, 等. 强脉冲光联合睑板腺按摩治疗睑板腺功能障碍的短期疗效[J]. 中华眼视光学与视觉科学杂志, 2019, 21(10): 769-775. doi:10.3760/cma.j.issn.1674-845X.2019.10.008. WANG Mengge, CHEN Dan, LI Liping, et al. Therapeutic effect of intense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2019, 21(10): 769-775. doi:10.3760/cma.j.issn.1674-845X.2019.10.008.
[1] 张钰曲毅. 眼弓形体病的发病机制及防治研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 70-76.
[2] 宋晴 宋西成. 安罗替尼联合治疗在肿瘤治疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 106-112.
[3] 张可人, 雷春燕, 张美霞. 眼睑松弛综合征伴阻塞性睡眠呼吸暂停1例[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 125-128.
[4] 王媚 李志海. 喉癌干细胞:克服多药耐药性的潜在治疗靶点[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 120-128.
[5] 熊攀辉,沈暘,杨玉成. 基于表型和内在型的慢性鼻窦炎诊治进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 15-19.
[6] 王欢,胡俐,余洪猛. 慢性鼻窦炎相关嗅觉功能障碍研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 43-49.
[7] 谷钰,万鑫,肖自安. 中性粒细胞和嗜酸性粒细胞在慢性鼻窦炎中的相互影响及临床治疗思考[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 56-63.
[8] 曾宪廷,王广科,孙占伟,武天义,李世超,王卫卫. 伴咽喉反流的难治性鼻窦炎术后应用质子泵抑制剂的疗效观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 189-194.
[9] 张陶然,王薇,李明铭,黄映湘. IVR治疗mCNV患者黄斑中心凹下脉络膜厚度分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 68-71.
[10] 狄宇，李莹. 干眼炎症反应机制及抗炎治疗的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 144-150.
[11] 庞冲,边赛男,张冰,尹旭,陆颖霞,叶鹏飞,王湛,赵晶,高彦,关凯. 儿童过敏性鼻炎粉尘螨特异性舌下免疫治疗短期疗效评估[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 70-74.
[12] 李孟辉,郅莉莉,戚凯文,王珊珊,高倩,步美玲,姜荷云,冯绛楠,王金荣. 皮下免疫治疗对单一尘螨和合并霉菌过敏儿童哮喘的临床研究[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 75-80.
[13] 陈坤,陆慧,黄琦,李磊,孟国珍,杨军,侯东明. 小儿先天性鼻腔鼻窦肿物的临床诊疗观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 81-85.
[14] 曾斌, 吕丹, 任佳, 胡娟娟, 于凌昱, 卢欢, 杨慧. 喉显微外科技术在严重新生儿上气道梗阻中的应用[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 95-99.
[15] 赵兴贺,樊明月,窦训武,贾广彪. 儿童原发扁桃体弥漫大B细胞淋巴瘤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 120-124.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 张晗,黄一飞 . 抗角膜移植排斥的研究进展[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 84 -87 .
[2] 牛善利,柴茂文,李振秀 . 鼻内镜下鼻甲成形术治疗慢性肥厚性鼻炎60例[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 16 -18 .
[3] 孟庆国,卢永田,范献良 . 杀伤细胞免疫球蛋白样受体基因多态性与鼻咽癌的关联性[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 196 -199 .
[4] 马玉起,孔祥春 . 先天性双侧下唇窦道1例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 199 -199 .
[5] 万俐佳,鲁海涛,姜义道,刘 辉,李 琴,佘腊枝 . 改良腭咽成形术治疗阻塞性睡眠呼吸暂停综合征41例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 204 -205 .
[6] 于青青 ,王跃建 . 硬质耳内镜的临床应用进展[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 222 -224 .
[7] 吉晓滨,邓家德,臧林泉,王 磊,谢 军 . 豚鼠变应性鼻炎模型血清组胺的测定[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 228 -230 .
[8] 向登,卢永田,孙焕吉 . 鼻内镜下修补脑脊液鼻漏19例并文献复习[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 234 -236 .
[9] 邱恩惠,李志春,方文旭 . 嗅觉障碍的中西医治疗[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 253 -257 .
[10] 殷国华,钟 笑 . 激光减容术治疗舌扁桃体肥大的远期疗效[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 280 -282 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发